Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth M Ruprecht

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Plos Pathogens|June 1, 2021
PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
The Journal of Infectious Diseases|March 11, 2010
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routesAgnès L Chenine, Nagadenahalli B Siddappa, Victor G Kramer, et al.
Vaccine|September 24, 2014
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virusSamir K Lakhashe, Siddappa N Byrareddy, Mingkui Zhou, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
AIDS Research and Human Retroviruses|August 6, 2024
PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal ExposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Journal of Virology|March 23, 2018
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus MacaquesDenise C Hsu, Piyanate Sunyakumthorn, Matthew Wegner, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Plos Pathogens|June 1, 2021
PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
The Journal of Infectious Diseases|March 11, 2010
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routesAgnès L Chenine, Nagadenahalli B Siddappa, Victor G Kramer, et al.
Vaccine|September 24, 2014
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virusSamir K Lakhashe, Siddappa N Byrareddy, Mingkui Zhou, et al.
Frontiers in Immunology|March 4, 2021
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV ChallengeDelphine C Malherbe, Lo Vang, Jason Mendy, et al.
AIDS Research and Human Retroviruses|August 6, 2024
PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal ExposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
Journal of Virology|May 11, 2018
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying <i>env</i> from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 TropismHanna B Scinto, Sandeep Gupta, Swati Thorat, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Journal of Virology|March 23, 2018
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus MacaquesDenise C Hsu, Piyanate Sunyakumthorn, Matthew Wegner, et al.
Pageof 11